These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33451862)

  • 1. Evaluation of tocilizumab for intractable Takayasu arteritis and
    Isobe M; Maejima Y; Saji M; Tateishi U
    J Cardiol; 2021 May; 77(5):539-544. PubMed ID: 33451862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
    Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
    Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
    Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
    Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
    Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review.
    Li H; Shuai Z
    Heart Vessels; 2022 May; 37(5):884-894. PubMed ID: 34750666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis.
    Kang L; Liu Y; Luo Z; Zhou Y; Chen B; Yin G; Xie Q
    Front Immunol; 2023; 14():1084558. PubMed ID: 36845158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous tocilizumab for Takayasu arteritis with aortic aneurysms, bilateral renal artery stenosis, and atypical aortic coarctation in a 2-year-old girl.
    Fujita Y; Tomiita M; Saida S; Omura S; Sato M; Otsubo Y; Takagi Y; Kano Y; Sekine K; Fukushima K; Kuwashima S; Yoshihara S
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):160-165. PubMed ID: 36018053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of severe colitis in Takayasu arteritis treated with tocilizumab.
    Ishii K; Shirai T; Kakuta Y; Machiyama T; Sato H; Ishii T; Harigae H; Fujii H
    Clin Rheumatol; 2022 Jun; 41(6):1911-1918. PubMed ID: 35188603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
    Nakaoka Y; Isobe M; Tanaka Y; Ishii T; Ooka S; Niiro H; Tamura N; Banno S; Yoshifuji H; Sakata Y; Kawakami A; Atsumi T; Furuta S; Kohsaka H; Suzuki K; Hara R; Maejima Y; Tsukamoto H; Takasaki Y; Yamashita K; Okada N; Yamakido S; Takei S; Yokota S; Nishimoto N
    Rheumatology (Oxford); 2020 Sep; 59(9):2427-2434. PubMed ID: 31951279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis.
    Prieto Peña D; Martínez-Rodríguez I; Atienza-Mateo B; Calderón-Goercke M; Banzo I; González-Vela MC; Castañeda S; Llorca J; González-Gay MÁ; Blanco R
    Clin Exp Rheumatol; 2021; 39 Suppl 129(2):69-75. PubMed ID: 33253103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of combination tocilizumab and glucocorticoids as an induction therapy in patients with Takayasu arteritis: An observational study.
    Yoshida S; Suzuki E; Matsumoto H; Yokose K; Fujita Y; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Watanabe H; Migita K
    Mod Rheumatol; 2023 Mar; 33(2):360-366. PubMed ID: 35438750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
    Decker P; Olivier P; Risse J; Zuily S; Wahl D
    Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Takayasu arteritis.
    Misra DP; Singh K; Rathore U; Kavadichanda CG; Ora M; Jain N; Agarwal V
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101826. PubMed ID: 37246052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis.
    Hanioka Y; Shimizu K; Yamagami K; Yao S; Nakamura R; Nakamura T; Goto H
    Intern Med; 2021 May; 60(10):1615-1620. PubMed ID: 33281154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab.
    Alibaz-Oner F; Kaymaz-Tahra S; Bayındır Ö; Yazici A; Ince B; Kalkan K; Kanıtez NA; Kocaer SB; Yasar Bilge NS; Omma A; Durak E; Ilgın C; Akar S; Kaşifoğlu T; Önen F; Emmungil H; İnanç M; Cefle A; Aksu K; Keser G; Direskeneli H
    Semin Arthritis Rheum; 2021 Dec; 51(6):1224-1229. PubMed ID: 34706312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.
    Singh A; Danda D; Hussain S; Najmi AK; Mathew A; Goel R; Lakhan SE; Tajudheen B; Antony B
    Mod Rheumatol; 2021 Jan; 31(1):197-204. PubMed ID: 32000551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
    Yoshifuji H
    Mod Rheumatol; 2019 Mar; 29(2):287-293. PubMed ID: 30427262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study.
    Wang J; Kong X; Ma L; Ding Z; Chen H; Chen R; Jin X; Chen C; Lin J; Jiang L
    Rheumatology (Oxford); 2024 May; 63(5):1359-1367. PubMed ID: 37540159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
    Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
    Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.